India's Orchid Pharma eyes worst day in 4 years on Q3 profit drop

Orchid Pharma

13/02/2025 08:23

** Orchid Pharma  ORCD.NS  tumbles 15.6% to 1,041.1 rupees
    ** Stock set for worst day since November 2020, with trading
volumes 9x the 30-day avg
    ** Co posts 29% Y/Y fall in Q3 consolidated profit; net
sales fell ~2%
    ** Sharp price correction in export markets offset volume
growth, said analysts at Systematix Institutional Equities
    ** Adds cash burn in branded formulation business also hurt
    ** Stock eyes fifth straight session of falls, and has shed
42% so far this year

 (Reporting by Ashna Teresa Britto in Bengaluru)
 ((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))